SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-13-002516
Filing Date
2013-05-09
Accepted
2013-05-09 12:12:41
Documents
14
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 372183
2 CERTIFICATION sbfm_ex311.htm EX-31.1 14736
3 CERTIFICATION sbfm_ex312.htm EX-31.2 14677
4 CERTIFICATION sbfm_ex32.htm EX-32 7360
11 img001.jpg GRAPHIC 38701
12 img002.jpg GRAPHIC 35401
13 img003.jpg GRAPHIC 27790
14 img004.jpg GRAPHIC 39597
  Complete submission text file 0001354488-13-002516.txt   1287357

Data Files

Seq Description Document Type Size
5 sbfm-20130331.xml EX-101.INS 35801
6 sbfm-20130331.xsd EX-101.SCH 9606
7 sbfm-20130331_cal.xml EX-101.CAL 22310
8 sbfm-20130331_def.xml EX-101.DEF 9967
9 sbfm-20130331_lab.xml EX-101.LAB 76775
10 sbfm-20130331_pre.xml EX-101.PRE 54832
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 13827440
SIC: 8742 Services-Management Consulting Services